Antimicrobial resistance profiles and genetic characterisation of macrolide resistant isolates of Streptococcus agalactiae

Memorias do Instituto Oswaldo Cruz

Volumn 106, Issue 2, 2011, Pages 119-122

  Nakamur, Priscila A M ^a   Schuab, Rôde Beatriz B ^a   Neves, Felipe P G ^a   Pereira, Cláudio F A ^a   de Paula, Geraldo R ^b   Barros, Rosana R ^a  

^a Inst Biomédico   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Antimicrobial resistance; Erythromycin resistance genes; Streptococcus agalactiae

Indexed keywords

ANTIINFECTIVE AGENT; ERYTHROMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; DRUG EFFECT; FEMALE; GENETIC VARIABILITY; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; YOUNG ADULT;

STREPTOCOCCUS AGALACTIAE;

EID: 79955452973     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762011000200001     Document Type: Article

References (22)

1. Alhambra A, Gómez-Garcés JL, Alós JI 2004. Susceptibility of Streptococcus agalactiae isolates from blood and urine to 18 widely used and recently marketed antibiotics. Clin Microbiol Infect 10: 267-268.
2. Beall B, Facklam R, Thompson T 1996. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 34: 953-958.
3. Borger IL, D'Oliveira REC, Castro ACD, Mondino SSB 2005. Streptococcus agalactiae em gestantes: prevalência de colonização e avaliação de suscetibilidade aos antimicrobianos. Rev Bras Gine-col Obstet 27: 575-579.
4. CLSI - Clinical Laboratory Standard Institute 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - eighth edition, M07-A8, Clinical Laboratory Standard Institute, Wayne, 10 pp.
5. CLSI - Clinical Laboratory Standard Institute 2009. Performance standards for antimicrobial disk susceptibility tests; approved standard - tenth edition, M02-A10, Clinical Laboratory Standard Institute, Wayne, 10 pp.
6. CLSI - Clinical Laboratory Standard Institute 2009. Performance standards for antimicrobial susceptibility testing, 19th informational supplement, M100-S19, Clinical Laboratory Standard Institute, Wayne, 10 pp.
7. de Azavedo JC, McGavin M, Duncan C, Low DE, McGeer A 2001. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother 45: 3504-3508.
8. d'Oliveira RE, Barros RR, Mendonça CR, Teixeira LM, Castro AC 2003. Susceptibility to antimicrobials and mechanisms of eryth-romycin resistance in clinical isolates of Streptococcus agalac-tiae from Rio de Janeiro, Brazil. J Med Microbiol 52: 1029-1030.
9. Duarte RS, Bellei BC, Miranda OP, Brito MA, Teixeira LM 2005. Distribution of antimicrobial resistance and virulence-related genes among Brazilian group B streptococci recovered from bovine and human sources. Antimicrob Agents Chemother 49: 97-103.
10. Duarte RS, Miranda OP, Bellei BC, Brito MA, Teixeira LM 2004. Phenotypic and molecular characteristics of Streptococcus aga-lactiae isolates recovered from milk of dairy cows in Brazil. J Clin Microbiol 42: 4214-4222.
11. Hannoun A, Shehab M, Khairallah MT, Sabra A, Abi-Rached R, Bazi T, Yunis KA, Araj GF, Matar GM 2009. Correlation between group B streptococcal genotypes, their antimicrobial resistance profiles and virulence genes among pregnant women in Lebanon. Int J Microbiol 2009: 1-6.
12. Kawamura Y, Fujiwara H, Mishima N, Tanaka Y, Tanimoto A, Ikawa S, Itoh Y, Ezaki T 2003. First Streptococcus agalactiae isolates highly resistant to quinolones with point mutations in gyrA and parC. Antimicrob Agents Chemother 47: 3605-3609.
13. Miró E, Rebollo M, Rivera A, Álvarez MT, Navarro F, Mirelis B, Coll P 2006. Streptococcus agalactiae altamente resistente a fluoro-quinolonas. Enferm Infec Microbiol Clin 24: 562-563.
14. Pérez-Trallero E, Montes M, Orden B, Tamayo E, García-Arenzana JM, Marimón JM 2007. Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005. Anti-microb Agents Chemother 51: 1228-1233.
15. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, Craig AS, Schaffner W, Zansky SM, Gershman K, Ste-fonek KR, Albanese BA, Zell ER, Schuchat A, Schrag SJ, Active Bacterial Core surveillance/Emerging Infections Program Network 2008. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 299: 2056-2065.
16. Pinheiro S, Radhouani H, Coelho C, Gonçalves A, Carvalho E, Carvalho JA, Ruiz-Larrea F, Torres C, Igrejas G, Poeta P 2009. Prevalence and mechanisms of erythromycin resistance in Streptococcus agalactiae from healthy pregnant women. Microb Drug Resist 15: 121-124.
17. Ruoff KL, Whiley RA, Beighton D 1999. Streptococcus. In PR Murray, EJ Baron, MA Pfaller, FC Tenover, RH Yolken, Manual of clinical microbiology, 7th ed., American Society for Microbiology, Washington DC, p. 283-296.
18. Schuchat A, Wenger JD 1994. Epidemiology of group B streptococcal disease. Risk factors, prevention strategies and vaccine development. Epidemiol Rev 16: 374-402.
19. Sendi P, Johansson L, Norrby-Teglund A 2008. Invasive group B streptococcal disease in non-pregant adults: a review with emphasis on skin and soft-tissue infections. Infection 36: 100-111.
20. Seppälä H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, Huovinen P, Finnish Group for Antimicrobial Resistance 1997. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 337: 441-446.
21. Tazi A, Gueudet T, Varon E, Gilly L, Trieu-Cuot P, Poyart C 2008. Fluoroquinolone-resistant group B streptococci in acute exacerbation of chronic bronchitis. Emerg Infect Dis 14: 349-350.
22. Ulett KB, Benjamin WH Jr, Zhuo F, Xiao M, Kong F, Gilbert GL, Schembri MA, Ulett GC 2009. Diversity of group B streptococcus serotypes causing urinary tract infections in adults. J Clin Microbiol 47: 2055-2060.